Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The macrophage recruitment and infiltration pathway is a complex biological process involving the mobilization of monocytes from the bone marrow and their subsequent migration into peripheral tissues, where they differentiate into macrophages (Nature Reviews Cancer, PMID: 24442438). This pathway is primarily driven by the interaction between chemokines, such as C-C Motif Chemokine Ligand 2 (CCL2), and their corresponding receptors, notably C-C Chemokine Receptor Type 2 (CCR2) (Frontiers in Immunology, PMID: 30107140). Additionally, Colony Stimulating Factor 1 (CSF1) and its receptor (CSF1R) play a critical role in the survival and differentiation of these recruited cells (Clinical Cancer Research, PMID: 27141351). In diseases like cancer, this pathway is exploited to populate the tumor microenvironment with tumor-associated macrophages (TAMs) that facilitate immunosuppression, angiogenesis, and metastasis (Journal of Hematology & Oncology, PMID: 33407734). Therapeutic strategies targeting this pathway focus on inhibiting these signaling nodes to prevent macrophage accumulation in pathological sites (Nature Reviews Cancer, PMID: 24442438). While highly relevant for drug discovery, this entry represents a multi-component physiological process rather than a single molecular target. Drugs like pexidartinib and carlumab have been developed to disrupt specific nodes within this recruitment cascade to achieve clinical benefit (Cell, PMID: 28985560).
Inhibition of chemokine-receptor interactions (e.g., CCL2-CCR2 axis) or growth factor signaling (e.g., CSF1-CSF1R axis) to block the mobilization, extravasation, and survival of monocytes and macrophages in diseased tissues.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage recruitment and infiltration pathway.